FDA Releases Draft Guidance for Chemistry, Manufacturing, and Control Reviewers of Human Somatic Cell Therapy INDs

Summary

The FDA has made available a draft document outlining instructions and a template for reviewers of human somatic cell therapy Investigational New Drug Applications (INDs) to assess and record relevant information, aiming to finalize the guidance by an unspecified date.